Dar Al-Thuraya Real Estate Co. K.S.C. (Public) (KWSE:THURAYA)

Ligand Pharmaceuticals Cash Flow Statement

Financials in millions KWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	2.38	2.34	0.32	0.4	0.88	0.56
Depreciation & Amortization	-	-	-	-	0	0
Gain (Loss) on Sale of Assets	-	-	-	-	-0.1	-
Gain (Loss) on Sale of Investments	-0.22	-0.28	0.04	0.01	-0.08	-0.18
Asset Writedown	-2	-2	-0.06	-0.18	-0.53	-0.44
Change in Accounts Receivable	-0.02	-0.01	-0.02	0.07	0.26	3.19
Change in Other Net Operating Assets	-0.54	-0.18	-0.28	0.44	1.64	1.46
Other Operating Activities	0.01	0.05	0.02	0	0.04	-0.14
Operating Cash Flow	-0.4	-0.09	0.01	0.38	2.66	4.14
Operating Cash Flow Growth	-	-	-96.36%	-85.63%	-35.94%	-
Acquisition of Real Estate Assets	-	-0.02	-	-0.9	-3.84	-11.75
Sale of Real Estate Assets	-	-	-	-	1.73	0.04
Net Sale / Acq. of Real Estate Assets	-	-0.02	-	-0.9	-2.11	-11.71
Investment in Marketable & Equity Securities	0.37	0.23	0.1	-	-	-
Other Investing Activities	0.02	0.02	0.02	0.02	0.01	0.15
Investing Cash Flow	0.39	0.23	0.12	-0.89	-2.11	-4.57
Short-Term Debt Repaid	-	-0.06	-0.07	-	-	-
Long-Term Debt Repaid	-	-0.1	-	-	-	-
Total Debt Repaid	-0.1	-0.16	-0.07	-	-	-
Net Debt Issued (Repaid)	-0.1	-0.16	-0.07	-	-	-
Other Financing Activities	-	-0.06	-0.04	-0.04	-0.02	-
Net Cash Flow	-0.11	-0.08	0.02	-0.55	0.52	-0.42
Cash Interest Paid	-	0.06	0.04	0.04	0.02	-
Levered Free Cash Flow	-0.47	2.9	-0.21	4.23	1.4	5.33
Unlevered Free Cash Flow	-0.44	2.94	-0.17	4.25	1.42	5.33
Change in Working Capital	-0.57	-0.19	-0.3	0.15	2.48	4.28

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.